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Abstract  
Objective: This study aims to analyze the patterns of morbidity amongst cancer patients attending a tertiary care hospital. 
Materials and Methods: Data were collected from various departments dealing in cancer care. Patient’s data were categorized according to 
diagnosis and place of residence. 
Results: A total of 1490 new cancer patients were registered. Out of these 1140 were Indians from 22 different states {males= 609 (53.4%) 
and females= 531 (46.6%)} and remaining 350 patients were from 27 different countries {males= 223 (63.7%) and females=127 (36.3%)}. 
The five most common cancer site groups amongst all males (n=832) were digestive organs (18.6%) followed by lymphoid, hematopoietic 
and related tissue (16.8%);  respiratory & intrathoracic organs (14.1%); then eye, brain and other parts of central nervous system (11.4%) and 
lip, oral cavity and  pharynx (9.5%)  and in all females (n=658) the most common cancer site were breast (31.5%) followed by  genital 
organs (17.3%); digestive organs (11.2%); lymphoid, hematopoietic and related tissue (9.3%) and eye, brain and other parts of nervous system 
(9.0%). 
Conclusions:  The present study highlights the pattern of cancer among patients in a corporate tertiary health care institute. 
There is therefore an inherent bias, the leading sites of malignancies amongst Indian males and females varied from that in the 
Western population; this could be attributed to various cultural, environmental factors, life style, genetic factors etc. in different 
regions of India and different nations of the world.  
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Introduction 
History of cancer registry is about four hundred years old. The first step was taken by the City of London, in the year 
of 1728, wherein an attempt was made to collect the data about cancer registration but little knowledge was gained 
from this experience[1]. In the year 1900 an attempt was made to register all the patients who were suffering from 
cancer and were under medical treatment in Germany[2]. For this purpose a questionnaire was made and distributed to 
all the physicians so as to create a record about the prevalence of cancer in Germany[3].  The need of cancer registry 
worldwide emerged from a conference held in Copenhagen in 1946 where twelve leading international oncologist 
recommended the establishment of cancer registration under the World Health Organization (WHO)[4]. As a result, 
World Health Organization in 1965, finally established the International Agency for Research on Cancer (IACR) 
located in Tokyo, Japan. 
Different nations in the world started to register patients suffering from cancer in their country and this process is 
called cancer registry. In India, the National Cancer Registry Programme (NCRP) was commenced by the Indian 
Council of Medical Research (ICMR), New Delhi with a network of cancer registries across the country in December 
1981. The main objectives of this programme were: 1- To generate reliable data on the magnitude and patterns of 
cancer; 2- To undertake epidemiological studies based on results of registry data; 3- To provide research base for 
developing appropriate strategies to aid in National Cancer Control Programme; this would be in the form of planning, 
monitoring and evaluation of activities under this programme; 4- To develop human resource in cancer registration 
and epidemiology[5].  
Among various diseases, cancer has become a big threat to human beings globally[6]. This is the second most 
common disease, after cardiovascular disorders, for maximum deaths in the world[7]. The world’s population is 
expected to be 7.5 billion by 2020 and approximations predict about 15.0 million new cancer cases will be diagnosed 
and there will be 12.0 million deaths[8].  In India there are approximately 2 – 2.5 million cases of cancer at any 
given point of time, with around 1 million new cases being detected each year and 0.5 million deaths per annum[9-10]. 
The number of cancer cases among males is estimated as 0.39 million and among females as 0.43 million[11]. Sen, U., 
Sankaranarayanan et al reported that the observed cancer patterns indicate that tobacco-control measures early 
detection of head and neck, breast and cervical cancers[12]. In India cancer of mouth, oropharynx, esophagus, 
stomach and lower respiratory tract are common in males and cancers of cervix, breast, mouth, oropharynx and 
esophagus are common in females[13]. There is a wide variation in the distribution of cancer throughout the world. 
These variations are attributed to multiple factors such as environmental factors, food habits, lifestyle, genetic factors 
etc. Very few studies have described the regional variation in cancer incidences in India. 
Salimuddin  Aziz et al reported that priorities and strategies for improving the standards of care should be 
defined[14]. The substantial variation in cancer rates in India suggests other risk factors or causative agents that 
remain to be discovered[15]. The study confirmed some known features of the geography of cancers in India[16]. 
Swaminathan, R. et al reported that cancer patterns were markedly different and population-based cancer survival was 
lower in rural areas than urban areas of India[17]. The outcome of a hospital based study will significantly to define 
region specific strategies for cancer treatment in eastern Uttar Pradesh[18]. In India, tobacco-related cancer can be 
prevented along with early detection and treatment, are important interventions for cancer control[19].  The study 
observed for further epidemiological investigations and the introduction of screening programme[20]. 
The purpose of a cancer registry program is to collect data regarding the patient’s name with unique identification 
number (UID to avoid repetition), age, gender, etiology, geographical distributions, type of cancer, site of cancer, 
grading and staging of cancer (to evaluate degree of invasion and metastasis), management, morbidity and mortality. 
This will help the higher authorities to make the required decision and to combat this deadly disease. The 
determination of cancer morbidity and mortality is important for future planning of resources, to assess preventive 
measures and to plan management strategies. The estimation of accurate and reliable current mortality statistics is a 
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part of interest and should be developed properly[21-22]. 
The International Classification of Disease (ICD) topography codes (ICD10: C00–C99)  are used for classification 
of cancer diseases  by using the Manual of International Statistical Classification of Disease and Related Health 
Problems (10
th
 revision) published by the World Health Organization[23].   
Aims and objectives  
(1) To conduct a hospital based study by studying the morbidity patterns of diseases registered at tertiary health 
care institute. 
(2) To observe the distribution of cancer morbidities by sex, age, cancer site and nationalities among the studied 
subjects. 
Background 
Fortis Memorial Research Institute, Gurgaon (FMRI) started the clinical service in July 2012. Covering an area of 11 acres with a 
vision to develop1000 beds, the hospital is built on the foundation of “trust” and rests on the four strong pillars -talent, technology, 
infrastructure and service. The Fortis Memorial Research Institute has a complete gamut of therapeutic and diagnostic 
technologies that are the “first” in India, in Asia and in some cases the “first” in the world too. Keeping the goal and vision in view, 
the hospital is the first institute in the world to have introduced radiation therapy in collaboration with the leading technology 
innovators Brain Lab and Elekta. The hospital also introduced the world’s first digital broadband MRI – the 3-Tesla Digital MRI.  
It also introduced the concept of Stem Cell Lab and Open Lab in India.  Hospital has full-fledged cancer services comprising 
departments of Medical Oncology and Haematology including Bone Marrow and Stem Cell Transplantation, 
Radiation Oncology and Surgical Oncology and supported by Nuclear Medicine and palliative care. 
Cancer Registration Methodology 
Cancer registry collects data on all new cases of cancer attending different outpatient departments in FMRI. There is a 
pre-devised questionnaire which records information on socio demographic, diagnosis, clinical extent of the disease, 
stage, treatment, prognosis of the disease etc. as recorded in the case records by the clinicians.  In case of multiple 
primary cancers in same person all these were counted as new.  There are some interment limitations in a 
retrospective study as the information about socioeconomic status, dietary habits, environmental factors and other risk 
factors are not always prerecorded. All the recorded data was entered in Microsoft Excel Data Sheet. All the 
information collected was cross-checked for completeness of data. The data were checked and validated by using of 
quality control programs/tools for cancer registries of International Agency for Research on Cancer (IARC) for 
avoiding duplication and any unlikely combinations of age, sex, site and morphology and other factors in the data base. 
It is to be mentioned that no ethical clearance was required to conduct this study.  
Statistical Analysis 
Collected data were entered in Microsoft Excel and the results generated were analyzed using software Statistical 
Package for Social Sciences (SPSS) version 21.0. Descriptive statistical measures such as percentage, mean, and 
standard deviation were applied. Inferential statistical tests such as Z- test and Chi-square test were applied to identify 
important relationships between variables. A p-value of < 0.05 was considered statistically significant and the results 
presented in form of suitable tables and figures. 
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Results 
This study pertains to the 1490 new malignant cases registered during 2013. Out of the 1490 cases registered, males 
were 832 (55.8%) and females were 658 (44.2%), had a sex ratio of males 1000 to females 791 (Table 1, Fig.1).  The 
age specific incidence rates for all cancer sites by sex were found to increase with age.  
 
Table 1 Number of cancers and percentages; Indian State and Other Countries by sex 
 
Place Male Female Total % (Total Cases z-test 
Indian States 
% 
609 531 1140 
76.5 2.3 (p<0.022) Statistically significant 
53.4 46.6 100.0 
Other Countries 
 % 
223 127 350 
23.5 4.9 (p<0.0001) Statistically significant 
63.7 36.3 100.0 
Total%  832 
55.9 
658 
44.1 
1490 
100.0 
100.0 4.5 (p<0.0001) Statistically significant 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Out of the 1490 registered cases, 1140 patients were from 22 Indian States, males were 609 (53.4%) and females 
were 531 (46.6%) with a sex ratio of males 1000 to females 872. Majority of the patients came from nearby states 
Haryana (37.0% ) followed by Delhi (30.3%), Uttar Pradesh (12.0%), Jammu & Kashmir (3.2%), Punjab (2.7%), 
Rajasthan (2.7%), Bihar (1.6%), Uttarakhand (1.3%), Madhya Pradesh (1.2%) & Assam (0.8%) respectively (Table 2 
and Fig.2 shows the distribution of cases according to states). 
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Table 2 Percentages of cancer cases by 10 leading Indian states and Other Countries 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The remaining 350 patients were from 27 other countries, males were 223 (63.7%) and females were 127 (36.3%) 
Rank Indian State Other Countries 
State % Country % 
1 Haryana 37.0 Iraq 58.9 
2 Delhi 30.3 Afghanistan 7.7 
3 Uttar Pradesh 12.0 Congo 7.4 
4 Jammu & Kashmir 3.2 Nigeria 7.4 
5 Punjab 2.7 Uzbekistan 2.0 
6 Rajasthan 2.5 Yemen 1.7 
7 Bihar 1.6 Kenya 1.4 
8 Uttarakhand 1.3 Rwanda 1.1 
9 Madhya Pradesh 1.2 Fiji 0.9 
10 Assam 0.8 Nepal 0.9 
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had a sex ratio of males 1000 to females 570. Maximum number of patients came to Fortis hospital for taking 
treatment were from Iraq  (58.9%)  followed by Afghanistan (7.7%), Congo (7.4%), Nigeria (7.4%), Uzbekistan 
(2.0%), Yemen (1.7%), Kenya (1.4%), Rwanda (1.1%), Fiji (0.9%) & Nepal (0.9%) respectively with number of 
Foreign Countries: 27 (Table 2 and Fig. 3 shows the statistics according to country). A statistically significant 
difference was observed between Indian citizens and other countries scenario (Z- statistic= 4.5, P<0.0001). 
The ten most common cancers as seen individually, in descending order of frequency amongst all males (n= 832) 
were, cancer of the brain, nervous system (11.4%) followed by cancer of lung (10.6%), non- hodgkin’s lymphoma 
(8.1%), prostate (6.4%), tongue (3.6%), liver (3.6%), bone (3.1%), colon (3.0%), kidney (3.0%) and stomach (2.8%) 
respectively. In all females (n= 658), breast (31.5%) was the leading site followed by brain nervous system (8.7%), 
ovary (6.4%), cervix uteri (5.9%), corpus uteri (4.4), NHL (3.6%), connective & soft tissue (2.6%), stomach (2.1%), 
oesophagus (2.0%) and gallbladder (2.0%) respectively (Table 3, Fig. 4 & Fig. 5). Several studies, from India and 
from other countries, have shown that leading sites of malignancies in males differ from those females[5, 6, 8-10, 24]. 
 
 
Table 3 Ten leading common cancers among Indian States & Other Countries by sex 
 
 
 
 
Rank Male Female 
ICD.10 Site % ICD.10 Site % 
1 C70-72 Brain, nervous system 11.4 C50 Breast 31.5 
2 C33-34 Lung 10.6 C70-72 Brain, nervous system 8.7 
3 C82-85 ,96 Non-Hodgkin’s Lymphoma 8.1 C56 Ovary 6.4 
4 C61 Prostate 6.4 C53 Cervix Uteri 5.9 
5 C01-02 Tongue 3.6 C54 Corpus uteri 4.4 
6 C22 Liver 3.6 C82-85 ,96 Non-Hodgkin’s Lymphoma 3.6 
7 C40-41 Bone 3.1 C47+49 Conn & Soft Tissue 2.6 
8 C18 Colon 3.0 C16 Stomach 2.1 
9 C64 Kidney 3.0 C16 Esophagus 2.0 
10 C16 Stomach 2.8 C23-24 Gallbladder 2.0 
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An evaluation of reliability of cancer data is usually measured by the percentage of patients having microscopic 
confirmation of diagnosis, as compared with other methods.  
Out of 1490 patients, 1445 (97.0%) were diagnosed microscopically including cytology, pathology and bone 
marrow for both sexes, males were 804 (96.6%) and females were 641 (97.4%) respectively (Table 4 & Fig.6). 
Microscopy as a common method of diagnosis has also been reported by other authors[8-10, 22, 24]. The number of 
patients who had microscopically confirmed diagnosis was statistically significant compared to those who had only 
radiological confirmation. 
 
Table 4 Distribution of most valid basis of diagnosis by sex 
 
Sl.  No. Basis of diagnosis Male Female Total 
1 
Microscopic 
Nos. 804 641 1445 
% 96.63 97.42 96.98 
2 
X-ray/Imaging 
Nos. 28 17 45 
% 3.37 2.58 3.02 
3 
Total 
Nos. 832 658 1490 
% 100.0 100.0 100.0 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As a part of disease management, patients were treated with either single modality or multiple treatment modalities. 
Table 5 shows details of treatment received by male and female patients. Out of 1490 cases, only 53.1% of male 
patients (442 out of 832) completed the treatment at the study centre.  Treatment modalities were received as detailed; 
34.7% primarily chemotherapy and/or radiotherapy and/or surgery, 22.5% primarily radiotherapy and/or chemotherapy and/or 
surgery; 13.2% primarily surgery and /or radiotherapy and /or chemotherapy. Single treatment given to males is as detailed; 
21.4% primarily chemotherapy, 9.7% primarily radiotherapy and 7.1% Surgery primarily (Fig. 7).  
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Table 5 Distribution of different modalities of treatment by sex  
Treatment modalities Male 
   Nos.                   % 
Female 
      Nos.                % 
z-test 
(p value) 
C 178 21.4 149 22.6 0.3 (p>0.05) NS 
C+R 74 8.9 33 5.0 0.7 (p>0.05) NS 
C+R+S 18 2.2 15 2.3 0.0 (p>0.05) NS 
C+S 18 2.2 32 4.9 0.0 (p>0.05) NS 
R 81 9.7 44 6.7 0.0 (p>0.05) NS 
R+S 14 1.7 10 1.5 0.6 (p>0.05) NS 
S 59 7.1 80 12.2 0.8 (p>0.05) NS 
NT 390 46.9 295 44.8 0.5 (p>0.05) NS 
Total 832 100.0 658 100.0 
4.4 (p<0.0001) 
Stat. significant 
% to total cases 55.8 44.2  
 
(R= Radiotherapy, C=Chemotherapy, S= Surgery and NT= No Treatment received) 
 
 
While among females, only 55.2% (353 out of 658) completed the treatment at the study centre, combination of 
treatment modalities were received; 34.8% primarily chemotherapy and /or radiotherapy and/or surgery, 15.5% primarily 
radiotherapy and /or chemotherapy and/or surgery and 20.9% Surgery primarily and /or chemotherapy and/or radiotherapy. 
Single treatment was given to females as detailed; 22.6% Chemotherapy, 6.7% Radiotherapy and Surgery 12.2% 
respectively (Fig.8).  
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Table 6 Gender wise distribution of the type of malignant neoplasm according to the ICD.10 classification 
S. NO. Site Groups ICD10 
Sex 
Total 
Male Female 
Cases % Cases % Cases % 
1 Lip, Oral Cavity & Pharynx C00-C14 79 9.55 22 3.37 101 6.88 
2 Digestive Organs C15-C26 155 18.61 74 11.23 229 15.41 
3 Respiratory & Intra Thorax Organ C30-C39 117 14.13 16 2.4 133 8.95 
4 Bone & Articular Cartilage  C40-C41 26 3.1 3 0.5 29 1.9 
5 Melanoma Of Skin  C43-C44 7 0.8 5 0.8 12 0.8 
6 Mesothelil & Soft Tissue  C45-C49 22 2.6 22 3.38 44 3.0 
7 Breast C50 2 0.2 207 31.51 209 14.02 
8 Female Genital Organs C51-C58 0 0.0 114 17.32 114 7.77 
9 Male Genital Organs  C60-C63 63 7.67 0 0.0 63 4.2 
10 Urinary Tract  C64-C68 49 5.98 10 1.5 59 4.0 
11 Eye, Brain & Ot Parts of CNS C69-C72 95 11.44 59 9.05 154 10.34 
12 Thyroid & Oth Endo Glands C73-C75 8 1.0 8 1.2 16 1.1 
13 ILL Defined Sec & Uns Sites  C76-C80 69 8.36 57 8.76 126 8.56 
14 Lymp, Haemato & Related Tissue C81-C96 140 16.82 61 9.34 201 13.53 
All Sites (C00-C96) 832 100.0 658 100.0 1490 100.0 
Superscript figures (1, 2, 3, 4, 5, 6, 7 and 8) are representing the rank order of the cancer site group (ICD.10) frequency. 
 
 
Gender-wise distributions of the type of malignant neoplasm according to the ICD.10 Classification are shown in Table 6. The 
leading sites of cancer in our population (separately for male and female) were;  
A) In male: cancer of digestive organs (18.6%), lymphoid, hematopoietic and related tissue (16.8%), respiratory & intra thoracic 
organs ( 14.3%), eye, brain & other parts of CNS (11.4%) and cancer of lip, oral cavity & pharynx (9.5%). 
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B) In females: cancer of breast (31.5%), female genital organs (17.3%), digestive organs (11.2%), lymphoid, hematopoietic and 
related tissue ( 9.3%) and cancer of eye, brain & other parts of CNS (9.0%) respectively. 
C) In both sexes: Cancer of digestive organs, lymphoid, hematopoietic and related tissue and cancer of eye, brain & other parts 
of CNS are the common cancers. 
 
Table 7 shows the distribution of cancer patients according to detailed cancer sites (ICD.10) for Indian states and other 
countries by sex. The superscript figures (1,2,3,4,5,6,7,8,9,10) are representing the rank order of the cancer sites 
(ICD.10) for total cases of Indian states and other countries by sex with percentages to total cases. Commonest cancer 
in males was lung and breast in females. 
Discussion 
Cancer incidences are rising worldwide. About 11 million new cases of cancer and 7 million deaths were notified due 
to cancer diseases in 2002[24].  The prevalence of cancer varies in different geographical areas and according to 
different population groups[25]. The common risk factors are classified as non-modifiable (genetic susceptibility and 
aging) and modifiable risk factors (tobacco, lifestyle, infectious agents, diet and physical activities[26]. The magnitude 
of cancer problem in the Indian Sub-continent is increasing because wide spread tobacco use, poverty and inadequate 
medical facilities[27]. In India, cancer has become one of the five leading causes of death. It is estimated, that there are 
nearly 2 - 2.5 million cancer cases at any given point of time. Current proportion suggest that total cancer burden in 
India for all sites of cancer, will double by 2026 because of increasing longevity, greater exposure to environmental 
carcinogens, continued use of tobacco and deteriorating life style. Combining the incidence of all cancers in both sexes 
worldwide, lung cancer is leading type of cancer followed by breast. In developing countries, the sequence is different 
with the most common being lung (11.5%) followed by stomach (10.6%), breast (8.8%), and liver (8.8%). Age is the 
single most common risk factors for cancer[28]. Tobacco, alcohol, diet, reproductive and sexual behaviour, occupation, 
pollution, industrial products, medicines, genetic predisposition, and geographical factors are the other important 
factors. Data from population based registries under National Cancer Registry Program (NCRP) in India indicate that 
the leading sites of cancer are oral cavity followed by lungs, esophagus and stomach amongst women in India. In male 
population Oral and esophageal cancers are amongst the highest in the world and cancers of colorectal and prostate are 
lowest. A significant variation of cancer sites has been reported due to life style, personal dietary habits, past history of 
illness and consumption of tobacco as the leading cause of cancers in India[29-31].  The causes of cancer, in India, 
are almost same as in other parts of world. The state wise distribution of different cancer patients in India is shown in 
Figure 9. A perusal of this figure clearly shows that different category of most common cancers in various states [9-10, 
22]. 
Fortis hospital delivers modern health care in multi disciplines, including Oncology. Oncology department is 
providing the world class cancer care in Medical, Radiation and Surgical oncology. Gurgaon is a metropolitan region 
on National Capital Territory with people of different ethnic groups residing here,  thus patients visiting this hospital 
are coming from different  Indian States (22 states) as well as other part of the world nation (27 countries).  
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Fig. 9 State wise depiction of the most incident cancers in India  
 
 
Conclusions 
As per the proverb, “prevention is better than cure” the prevention strategies are crucial in cancer eradication. This 
approach offers a great public health concern and inexpensive long term method of cancer control. India is a growing 
country playing a crucial role in the development of the whole world, and hence, needs special attention on this issue. 
Diet and life style are important in controlling the spread of cancers and hence, observed pattern of cancers in hospital 
may guide health managers in strengthening and remodeling health care facilities in health institutions for attaining 
better satisfaction levels of both patients as well as health care providers. Further multi-centric, long-term studies with 
wider coverage are desirable for studying disease trends suggesting better planning strategies. 
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Table7 Number of cancers by site (ICD.10) and place (Indian States & Other Countries) by sex 
ICD.10 Site 
Indian States Other Countries Total 
M F T M F T M F T % 
C00 Lip 0 0 0 0 0 0 0 0 0 0.0 
C01-02 Tongue 29 9 38 1 0 1 30 9 39 2.6 
C03-06 Mouth 21 7 28 0 0 0 21 7 28 1.9 
C07-08 Salivary Gland 3 0 3 0 1 1 3 1 4 0.3 
C09 Tonsil 4 0 4 0 0 0 4 0 4 0.3 
C10 Oth. Oropharynx 2 0 2 0 0 0 2 0 2 0.1 
C11 Nasopharynx 6 2 8 5 3 8 11 5 16 1.1 
C12-13 Hypo pharynx 6 0 6 1 0 1 7 0 7 0.5 
C14 Pharynx Uns 1 0 1 0 0 0 1 0 1 0.1 
C15 Esophagus 19 12 31 2 1 3 21 1310 34 2.3 
C16 Stomach 15 9 24 8 5 13 23 149 37 2.5 
C17 Small Intestine 0 1 1 1 0 1 1 1 2 0.1 
C18 Colon 17 11 28 8 1 9 259 12 37 2.5 
C19-20 Rectum 16 5 21 5 1 6 21 6 27 1.8 
C21 Anus & Anal Can.  2 0 2 0 0 0 2 0 2 0.1 
C22 Liver 17 9 26 13 0 13 307 9 399 2.6 
C23-24 Gall Bladder  11 13 24 4 0 4 15 13 28 1.9 
C25 Pancreas 10 5 15 6 1 7 16 6 22 1.5 
C30-31 Nose, Sinus etc. 1 0 1 2 1 3 3 1 4 0.3 
C32 Larynx 17 1 18 6 0 6 23 1 24 1.6 
C33-34 Lung etc. 71 12 83 17 1 18 882 13 1014 6.8 
C37-38 Other Thoracic Or  1 1 2 2 0 2 3 1 4 0.3 
C40-41 Bone 8 2 10 18 1 19 268 3 29 1.9 
C43 Melanoma of Skin 0 1 1 2 2 4 2 3 5 0.3 
C44 Other Skin 3 2 5 2 0 2 5 2 7 0.5 
C45 Mesothelioma 0 3 3 1 0 1 1 3 4 0.3 
C46 Kaposi Sarcoma 0 0 0 0 0 0 0 0 0 0.0 
C47+49 Con.& Soft tissue  13 9 22 8 8 16 21 178 38 2.6 
C50 Breast 1 172 173 1 35 36 2 2071 2091 14.0 
C51 Vulva 0 2 2 0 0 0 0 2 2 0.1 
C53 Cervix Uteri 0 29 29 0 10 10 0 395 3910 2.6 
C54 Corpus Uteri 0 26 26 0 3 3 0 296 29 1.9 
C55 Uterus Unsp.  0 1 1 0 0 0 0 1 1 0.1 
C56 Ovary etc. 0 37 37 0 5 5 0 424 427 2.8 
C58 Placenta 0 1 1 0 0 0 0 1 1 0.1 
C61 Prostate 35 0 35 18 0 18 535 0 536 3.6 
C62 Testis 5 0 5 5 0 5 10 0 10 0.7 
C64 Kidney 19 3 22 6 3 9 2510 6 31 2.1 
C65 Renal Pelvis 1 0 1 0 0 0 1 0 1 0.1 
C67 Bladder 11 1 12 12 3 15 23 4 27 1.8 
C69 Eye 0 0 0 0 2 2 0 2 2 0.1 
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*O & U:- Includes the site C26, C39, C48, C75, C76, C77, C78, C79, C80 & C97 
Superscript figures (1, 2, 3, 4, 5, 6, 7, 8, 9 & 10) are representing the rank order of the cancer site (ICD.10) frequency. 
 
 
C70-72 Brain, nervous sy.  78 48 126 17 9 26 951 573 1522 10.2 
C73 Thyroid 4 7 11 0 1 1 4 8 12 0.8 
C74 Adrenal Gland 1 0 1 1 0 1 2 0 2 0.1 
C81 Hodgkin’s dis.  16 6 22 3 5 8 19 11 30 2.0 
C82-85,96 NHL 55 20 75 12 4 16 674 247 911 6.1 
C88 Immuno proli dise 0 1 1 0 0 0 0 1 1 0.1 
C90 Multiple Myeloma 11 1 12 8 3 11 19 4 23 1.5 
C91 Lymphoid  Leuk.  10 8 18 3 5 8 13 13 26 1.7 
C92-94 Myeloid Leukemia 10 4 14 8 1 9 18 5 23 1.5 
C95 Leukemia  Uns 2 3 5 2 0 2 4 3 7 0.5 
0 & U* Other and uns 57 47 104 15 12 27 723 592 1313 8.8 
Total 609 531 1140 223 127 350 832 658 1490 100.0 
% 40.9 35.6 76.5 15.0 8.5 23.5 55.8 44.2 100.0   
